Caricamento...
Communication of Survival Data in US Food and Drug Administration–Approved Labeling of Cancer Drugs
This cross-sectional study examines how information on overall survival benefits of novel cancer drug indications is communicated in labeling.
Salvato in:
| Pubblicato in: | JAMA Intern Med |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Medical Association
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8276121/ https://ncbi.nlm.nih.gov/pubmed/34251420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2021.3505 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|